249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients
-
* Corresponding author: Suzane K Ono-Nita skon@usp.br
BMC Cancer 2009, 9:204 doi:10.1186/1471-2407-9-204
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 22 Jan 2008 | |
| Reviewer's Report | Michael Kew | 28 Feb 2008 | |
| Reviewer's Report | pascal pineau | 02 Apr 2008 | |
| Reviewer's Report | Mehmet Ozturk | 05 Apr 2008 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 13 May 2008 |
| Reviewer's Report | pascal pineau | 05 Jun 2008 | |
| Reviewer's Report | Mehmet Ozturk | 08 Jun 2008 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 29 Jul 2008 |
| Reviewer's Report | Mehmet Ozturk | 12 Aug 2008 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 01 Mar 2009 |
| Reviewer's Report | Mehmet Ozturk | 02 Apr 2009 | |
| Resubmission - Version 5 | Manuscript | Author's comment | 05 May 2009 |
| Editorial acceptance | 07 May 2009 | ||
| Published | 26 Jun 2009 |